News

Mar 30,2021

Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors

Mar 17,2021

Alveo Technologies' be.well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition

Mar 09,2021

Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Feb 25,2021

CULLGEN CLOSES $50 MILLION SERIES B INVESTMENT TO ADVANCE TARGETED PROTEIN DEGRADERS AND NOVEL E3 LIGANDS PLATFORM

Jan 13,2021

Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

Jan 06,2021

C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022

Dec 17,2020

C4 THERAPEUTICS TO BE ADDED TO THE RUSSELL 2000® AND RUSSELL 3000® INDEXES

No more pages to load

Next page